These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 10626249)

  • 41. A dual role for both CD40-ligand and TNF-alpha in controlling human B cell death.
    Lens SM; Tesselaar K; den Drijver BF; van Oers MH; van Lier RA
    J Immunol; 1996 Jan; 156(2):507-14. PubMed ID: 8543800
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Chronic morphine treatment promotes specific Th2 cytokine production by murine T cells in vitro via a Fas/Fas ligand-dependent mechanism.
    Greeneltch KM; Kelly-Welch AE; Shi Y; Keegan AD
    J Immunol; 2005 Oct; 175(8):4999-5005. PubMed ID: 16210602
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Differential regulation of CD95 (Fas/APO-1) expression in human blood eosinophils.
    Luttmann W; Opfer A; Dauer E; Foerster M; Matthys H; Eibel H; Schulze-Osthoff K; Kroegel C; Virchow JC
    Eur J Immunol; 1998 Jul; 28(7):2057-65. PubMed ID: 9692873
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Fas/FasL interaction is not involved in apoptosis of activated CD4+ T cells upon HIV-1 infection in vitro.
    Yagi T; Sugimoto A; Tanaka M; Nagata S; Yasuda S; Yagita H; Kuriyama T; Takemori T; Tsunetsugu-Yokota Y
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Aug; 18(4):307-15. PubMed ID: 9704935
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Melanoma cell expression of Fas(Apo-1/CD95) ligand: implications for tumor immune escape.
    Hahne M; Rimoldi D; Schröter M; Romero P; Schreier M; French LE; Schneider P; Bornand T; Fontana A; Lienard D; Cerottini J; Tschopp J
    Science; 1996 Nov; 274(5291):1363-6. PubMed ID: 8910274
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Apotosis of mature B cells.
    Tsubata T
    Int Rev Immunol; 1999; 18(4):347-65. PubMed ID: 10626248
    [TBL] [Abstract][Full Text] [Related]  

  • 47. CD40- and HLA-DR-mediated cell death pathways share a lot of similarities but differ in their use of ADP-ribosyltransferase activities.
    Léveillé C; Zekki H; Al-Daccak R; Mourad W
    Int Immunol; 1999 May; 11(5):719-30. PubMed ID: 10330277
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Resistance to Fas (APO-1/CD95)-mediated apoptosis and expression of Fas ligand in esophageal cancer: the Fas counterattack.
    O'Connell J; Bennett MW; O'Sullivan GC; Collins JK; Shanahan F
    Dis Esophagus; 1999; 12(2):83-9. PubMed ID: 10466039
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Constitutive caspase activation and impaired death-inducing signaling complex formation in CD95-resistant, long-term activated, antigen-specific T cells.
    Strauss G; Knape I; Melzner I; Debatin KM
    J Immunol; 2003 Aug; 171(3):1172-82. PubMed ID: 12874203
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Zeta-associated protein of 70 kDa (ZAP-70), but not Syk, tyrosine kinase can mediate apoptosis of T cells through the Fas/Fas ligand, caspase-8 and caspase-3 pathways.
    Zhong L; Wu CH; Lee WH; Liu CP
    J Immunol; 2004 Feb; 172(3):1472-82. PubMed ID: 14734724
    [TBL] [Abstract][Full Text] [Related]  

  • 51. APO-1 (CD95)-dependent and -independent antigen receptor-induced apoptosis in human T and B cell lines.
    Peter ME; Dhein J; Ehret A; Hellbardt S; Walczak H; Moldenhauer G; Krammer PH
    Int Immunol; 1995 Nov; 7(11):1873-7. PubMed ID: 8580085
    [TBL] [Abstract][Full Text] [Related]  

  • 52. IL-4 diminishes perforin-mediated and increases Fas ligand-mediated cytotoxicity In vivo.
    Aung S; Graham BS
    J Immunol; 2000 Apr; 164(7):3487-93. PubMed ID: 10725701
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Immature B cells in bone marrow express Fas/FasL.
    Nilsson N; Ingvarsson S; Borrebaeck CA
    Scand J Immunol; 2000 Mar; 51(3):279-84. PubMed ID: 10736097
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Suppression of human B cell responsiveness by CD4+ T cells does not involve CD95-CD95 ligand interactions.
    Hirohata S
    Cell Immunol; 1997 Nov; 181(2):182-91. PubMed ID: 9398405
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Role of Fas-mediated cell death in the regulation of immune responses.
    Van Parijs L; Abbas AK
    Curr Opin Immunol; 1996 Jun; 8(3):355-61. PubMed ID: 8793992
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The role of CD40-CD40 ligand interactions in suppression of human B cell responsiveness by CD4+ T cells.
    Hirohata S
    Cell Immunol; 1997 Nov; 182(1):20-8. PubMed ID: 9427806
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The Fas death factor.
    Nagata S; Golstein P
    Science; 1995 Mar; 267(5203):1449-56. PubMed ID: 7533326
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cross-talk between tumor cells and neutrophils through the Fas (APO-1, CD95)/FasL system: human glioma cells enhance cell viability and stimulate cytokine production in neutrophils.
    Hor WS; Huang WL; Lin YS; Yang BC
    J Leukoc Biol; 2003 Mar; 73(3):363-8. PubMed ID: 12629150
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Activated B cells express functional Fas ligand.
    Hahne M; Renno T; Schroeter M; Irmler M; French L; Bornard T; MacDonald HR; Tschopp J
    Eur J Immunol; 1996 Mar; 26(3):721-4. PubMed ID: 8605944
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Critical role for perforin-, Fas/FasL-, and TNFR1-mediated cytotoxic pathways in down-regulation of antigen-specific T cells during persistent viral infection.
    Zhou S; Ou R; Huang L; Moskophidis D
    J Virol; 2002 Jan; 76(2):829-40. PubMed ID: 11752172
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.